Affordable Access

Treatment of patients with advanced cancer using multiple long-term cultured lymphokine-activated killer (LAK) cell infusions and recombinant human interleukin-2.

Authors
Type
Published Article
Journal
Journal of biological response modifiers
0732-6580
Publication Date
Volume
8
Issue
5
Pages
468–478
Identifiers
PMID: 2795092
Source
Medline

Abstract

Statistics

Seen <100 times